Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin Assumption Effects

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions

Oxidative StressAlcohol Drinking

Interventions

DIETARY_SUPPLEMENT

Si.Pi.Mi product

Assumption of the product as detailed in the protocol

OTHER

Placebo

Assumption of placebo

Trial Locations (1)

Department of Biomedical Sciences, Padua

All Listed Sponsors

lead

University of Padova

OTHER

NCT06548503 - Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin Assumption Effects | Biotech Hunter | Biotech Hunter